Purple Biotech has entered a Phase II trial with its small molecule drug, NT219, focusing on patients with ...
Mohs surgery significantly improved recurrence, metastasis, and mortality rates in patients with primary high-stage cutaneous ...
8d
Live Science on MSN100-year-old heart drug made from foxglove may help 'dissolve' clumps of spreading cancer cellsThe heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...
12d
News Medical on MSNResearchers discover strategy to slow brain metastases growth in melanomaBrain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...
A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a ...
Researchers have identified a key role microglia play in melanoma brain metastases progression and mechanisms to target them.
Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal ...
Proactive onco-coaching did not improve quality of life but was linked to better overall survival in patients with metastatic ...
6d
StudyFinds on MSNNew light-activated salt treatment targets aggressive breast cancer with precisionDiscover the latest advancements in breast cancer treatment combining specialized salt and near-infrared light to target ...
Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...
A new research paper was published in Oncotarget, Volume 16, on February 12, 2025, titled “Could Panitumumab with very low ...
2d
Medpage Today on MSNAdd-On Cemiplimab Shows Promise as First-Line Treatment for Penile CancerSAN FRANCISCO -- A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results